Genetic Dissection and Clinical Features of MODY6 (NEUROD1-MODY)
1Department of Diabetes and Endocrinology, Graduate School of Medicine, Gifu University, 1-1 Yanagido, Gifu city, Gifu, 501-1194, Japan. yhorikaw@gifu-u.ac.jp.
Purpose Of Review:
MODY6 due to mutations in the gene NEUROD1 is very rare, and details on its clinical manifestation and pathogenesis are scarce. In this review, we have summarized all reported cases of MODY6 diagnosed by genetic testing, and examined their clinical features in detail.
Recent Findings:
MODY6 is a low penetrant MODY, suggesting that development of the disease is affected by genetic modifying factors, environmental factors, and/or the effects of interactions of genetic and environmental factors, as is the case with MODY5. Furthermore, while patients with MODY6 can usually achieve good glycemic control without insulin, when undiagnosed they are prone to become ketotic with chronic hyperglycemia, and microangiopathy can progress. MODY6 may also cause neurological abnormalities such as intellectual disability. MODY6 should be diagnosed early and definitively by genetic testing, so that the correct treatment can be started as soon as possible to prevent chronic hyperglycemia.
Insights
Maturity-Onset Diabetes of the Young type 6 (MODY6), caused by NEUROD1 gene mutations, is rare. Early genetic diagnosis is crucial for managing hyperglycemia and preventing complications like neurological issues.
Area of Science:
- Genetics
- Endocrinology
- Neurology
Background:
- MODY6 is a rare subtype of diabetes mellitus caused by mutations in the NEUROD1 gene.
- Information regarding its clinical presentation and pathogenesis is limited.
- It is characterized by low penetrance, suggesting influence from genetic and environmental factors.
Purpose of the Study:
- To review and consolidate all reported cases of MODY6 diagnosed via genetic testing.
- To provide a detailed examination of the clinical features associated with MODY6.
Main Methods:
- Systematic review of literature.
- Analysis of clinical data from genetically confirmed MODY6 cases.
Main Results:
- Patients with MODY6 may present with chronic hyperglycemia and are at risk of ketosis if undiagnosed.
- Microvascular complications and neurological abnormalities, including intellectual disability, can occur.
- Good glycemic control is often achievable without insulin in diagnosed patients.
Conclusions:
- Early and definitive diagnosis of MODY6 through genetic testing is essential.
- Prompt diagnosis facilitates timely treatment initiation to prevent chronic hyperglycemia and its associated complications.
More Related Videos
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Endocarditis II: Clinical Features of Infective Endocarditis
Pericarditis II: Clinical Features and Diagnostic Tests
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Myocarditis II: Clinical Features and Diagnostic Tests


